The formation of quasi-regular polymeric network of cross-linked sulfobutyl ether derivative of β-cyclodextrin synthesized with moxifloxacin as a template

[1]  E. Kudryashova,et al.  Effect of cross-linking on the inclusion complex formation of derivatized β-cyclodextrins with small-molecule drug moxifloxacin. , 2020, Carbohydrate research.

[2]  D. Alotto,et al.  In Vitro Enhanced Skin Permeation and Retention of Imiquimod Loaded in β-Cyclodextrin Nanosponge Hydrogel , 2019, Pharmaceutics.

[3]  I. Camele,et al.  Biological Investigations and Spectroscopic Studies of New Moxifloxacin/Glycine‐Metal Complexes. , 2019, Chemistry & biodiversity.

[4]  Jaehwi Lee,et al.  Enhancement of Aqueous Solubility and Dissolution of Celecoxib through Phosphatidylcholine-Based Dispersion Systems Solidified with Adsorbent Carriers , 2018, Pharmaceutics.

[5]  E. Kudryashova,et al.  Physicochemical Properties of the Inclusion Complex of Moxifloxacin with Hydroxypropyl-β-Cyclodextrin Synthesized by RESS , 2018, Russian Journal of Physical Chemistry B.

[6]  F. Toma,et al.  Equilibrium, structural and antibacterial characterization of moxifloxacin-β-cyclodextrin complex , 2018, Journal of Molecular Structure.

[7]  E. Kudryashova,et al.  The Effect of Molecular Architecture of Sulfobutyl Ether β-Cyclodextrin Nanoparticles on Physicochemical Properties of Complexes with Moxifloxacin , 2018, Colloid Journal.

[8]  E. Kudryashova,et al.  Targeted delivery of anti-tuberculosis drugs to macrophages: targeting mannose receptors , 2018 .

[9]  A. Schmidtchen,et al.  Membrane interactions and antimicrobial effects of layered double hydroxide nanoparticles. , 2017, Physical chemistry chemical physics : PCCP.

[10]  E. Kudryashova,et al.  Drug delivery systems for fluoroquinolones: New prospects in tuberculosis treatment , 2017, Russian Journal of Bioorganic Chemistry.

[11]  E. Kudryashova,et al.  Thermodynamics and molecular insight in guest–host complexes of fluoroquinolones with β-cyclodextrin derivatives, as revealed by ATR-FTIR spectroscopy and molecular modeling experiments , 2017, Analytical and Bioanalytical Chemistry.

[12]  V. Brunella,et al.  Molecularly imprinted cyclodextrin nanosponges for the controlled delivery of L-DOPA: perspectives for the treatment of Parkinson’s disease , 2016, Expert opinion on drug delivery.

[13]  Fei Liu,et al.  Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for tea polyphenol encapsulation , 2016 .

[14]  I. Deygen,et al.  New versatile approach for analysis of PEG content in conjugates and complexes with biomacromolecules based on FTIR spectroscopy. , 2016, Colloids and surfaces. B, Biointerfaces.

[15]  E. Kudryashova,et al.  Structure and stability of fluoroquinolone-(2-hydroxypropyl)-β-cyclodextrin complexes as perspective antituberculosis drugs , 2016, Moscow University Chemistry Bulletin.

[16]  A. Mortazavi,et al.  Chitosan gel-embedded moxifloxacin niosomes: An efficient antimicrobial hybrid system for burn infection. , 2016, International journal of biological macromolecules.

[17]  M. Refat,et al.  Quick and simple formation of different nanosized charge-transfer complexes of the antibiotic drug moxifloxacin: An efficient way to remove and utilize discarded antibiotics , 2015 .

[18]  N. Tabary,et al.  Cationic β-cyclodextrin polymer applied to a dual cyclodextrin polyelectrolyte multilayer system. , 2015, Carbohydrate polymers.

[19]  F. Atyabi,et al.  Preparation and Antibacterial Activity Evaluation of 18-β-glycyrrhetinic Acid Loaded PLGA Nanoparticles , 2015, Iranian journal of pharmaceutical research : IJPR.

[20]  J. Dewulf,et al.  Fluoroquinolone antibiotics: an emerging class of environmental micropollutants. , 2014, The Science of the total environment.

[21]  Nan Song,et al.  Reverse micelles based on β-cyclodextrin-incorporated amphiphilic polyurethane copolymers for protein delivery , 2014 .

[22]  P. Castro,et al.  Degradation of fluoroquinolone antibiotics and identification of metabolites/transformation products by liquid chromatography-tandem mass spectrometry. , 2014, Journal of chromatography. A.

[23]  A. Badwan,et al.  Moxifloxacin hydrochloride. , 2014, Profiles of drug substances, excipients, and related methodology.

[24]  S. Vyas,et al.  Tuberculosis: from molecular pathogenesis to effective drug carrier design. , 2012, Drug discovery today.

[25]  Ming Jiang,et al.  Cyclodextrin-based inclusion complexation bridging supramolecular chemistry and macromolecular self-assembly. , 2011, Chemical Society reviews.

[26]  A. Nokhodchi,et al.  Development of azithromycin-PLGA nanoparticles: physicochemical characterization and antibacterial effect against Salmonella typhi. , 2010, Colloids and surfaces. B, Biointerfaces.

[27]  Jun Li,et al.  Self-assembled supramolecular hydrogels based on polymer-cyclodextrin inclusion complexes for drug delivery , 2010 .

[28]  Linhong Deng,et al.  Sulfoalkyl ether β-cyclodextrin derivatives synthesized by a single step method as pharmaceutical biomaterials , 2009 .

[29]  A. Ludwig,et al.  Adhesion of PLGA or Eudragit/PLGA nanoparticles to Staphylococcus and Pseudomonas. , 2008, International journal of pharmaceutics.

[30]  Jun Li,et al.  Cationic star polymers consisting of alpha-cyclodextrin core and oligoethylenimine arms as nonviral gene delivery vectors. , 2007, Biomaterials.

[31]  Long-xiao Liu,et al.  A study on the supramolecular structure of inclusion complex of β-cyclodextrin with prazosin hydrochloride , 2007 .

[32]  Y. Egawa,et al.  Preparation of molecularly imprinted cyclodextrin microspheres. , 2005, International journal of pharmaceutics.

[33]  A. Harada,et al.  Formation of Supramolecular Polymers Constructed by Cyclodextrins with Cinnamamide , 2004 .

[34]  E. D. Valle,et al.  Cyclodextrins and their uses: a review , 2004 .

[35]  R. Darcy,et al.  Cell transfection with polycationic cyclodextrin vectors. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[36]  R. Chadha,et al.  Account of Analytical Techniques Employed for the Determination of Thermodynamics of Inclusion Complexation of Drugs with Cyclodextrins , 2004 .

[37]  K. Vårum,et al.  Interactions between chitosans and bacterial suspensions: adsorption and flocculation , 2003 .

[38]  S. Cooper,et al.  Interactions between dendrimer biocides and bacterial membranes. , 2002, Biomaterials.

[39]  K. Kano,et al.  Chiral recognition of helical metal complexes by modified cyclodextrins. , 2001, Journal of the American Chemical Society.

[40]  D. Fish.  Fluoroquinolone Adverse Effects and Drug Interactions , 2001, Pharmacotherapy.

[41]  K. Harata,et al.  Crystal structures of 6-deoxy-6-monosubstituted β-cyclodextrins. Substituent-regulated one-dimensional arrays of macrocycles , 2001 .

[42]  P. Appelbaum,et al.  The fluoroquinolone antibacterials: past, present and future perspectives. , 2000, International journal of antimicrobial agents.

[43]  K. Harata.  Structural Aspects of Stereodifferentiation in the Solid State. , 1998, Chemical reviews.

[44]  T. Loftsson,et al.  Cyclodextrin solubilization of ETH-615, a zwitterionic drug. , 1998, Drug development and industrial pharmacy.

[45]  M. Vaara.  Agents that increase the permeability of the outer membrane , 1992 .

[46]  É. Fenyvesi,et al.  Induced circular-dichroism spectra of complexes of cyclomalto-oligosaccharides and azo dyes containing naphthalene nuclei☆ , 1992 .

[47]  S. Williams,et al.  Cloning of human purine-nucleoside phosphorylase cDNA sequences by complementation in Escherichia coli. , 1983, Proceedings of the National Academy of Sciences of the United States of America.